Skip to main content
SpringerLink
Log in

Precocious Puberty: Clinical Management

  • Chapter
  • First Online:
Pediatric Endocrinology

Part of the book series: Contemporary Endocrinology ((COE))

  • 2771 Accesses

Abstract

Precocious puberty has been a focus of interest for both the pediatric ­endocrinologist and the primary pediatrician for many years. Thirty years ago (1980s), the development and application of GnRH agonist (GnRHa) therapy to treat central precocious puberty significantly changed our approach to this disorder. More recently, application of molecular biological techniques has provided us with a better understanding of the intricacies of the regulation of gonadotropin and sex-steroid production characteristic of normal pubertal development and provided us with the tools to elucidate the etiologies of previously uncharacterized disorders of precocious puberty.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Grumbach MM, Kaplan SL. Recent advances in the diagnosis and management of sexual precocity. Acta Paediatr Jpn. 1988;30(Suppl):155–75.

    PubMed  Google Scholar 

  2. Schwanzel-Fukuda M, et al. Migration of luteinizing hormone-releasing hormone (LHRH) neurons in early human embryos. J Comp Neurol. 1996;366:547–57.

    Article  PubMed  CAS  Google Scholar 

  3. Plant TM, et al. The arcuate nucleus and the control of gonadotropin and prolactin secretion in the female rhesus monkey (Macaca mulatta). Endocrinology. 1978;102(1):52–62.

    Article  PubMed  CAS  Google Scholar 

  4. Mueller PL, et al. Hormone ontogeny in the ovine fetus. IX. Luteinizing hormone and follicle-stimulating hormone response to luteinizing hormone-releasing factor in mid-and late gestation and in the neonate. Endocrinology. 1981;108(3):881–6.

    Article  PubMed  CAS  Google Scholar 

  5. Sklar CA, et al. Hormone ontogeny in the ovine fetus. VII. Circulating luteinizing hormone and follicle-stimulating hormone in mid-and late gestation. Endocrinology. 1981;108(3):874–80.

    Article  PubMed  CAS  Google Scholar 

  6. Winter JS, et al. Gonadotrophins and steroid hormones in the blood and urine of prepubertal girls and other primates. Clin Endocrinol Metab. 1978;7(3):513–30.

    Article  PubMed  CAS  Google Scholar 

  7. Zsarmovsky AH, Garcia-Segura TL, Horvath LM, Naftolin BF. Plasticity of the hypothalamic GABA system and their relationship with GnRH neurons during positive gonadotropin feedback in non-human primates in 82nd Annual Meeting of the Endocrine Society; 2000; Toronto, ON, Canada.

    Google Scholar 

  8. Zhang SJ, Jackson MB. GABA-activated chloride channels in secretory nerve endings. Science. 1993; 259:531–4.

    Article  PubMed  CAS  Google Scholar 

  9. Terasawa EF, Fernandez DL. Neurobiological mechanisms of the onset of puberty in primates. Endocr Rev. 2001;22(1):111–51.

    Article  PubMed  CAS  Google Scholar 

  10. Dhom G. The prepubertal and pubertal growth of the adrenal (adrenarche). Beitr Pathol. 1973;150(4): 357–77.

    Article  PubMed  CAS  Google Scholar 

  11. Sklar CA, Kaplan SL, Grumbach MM. Evidence for dissociation between adrenarche and gonadarche: studies in patients with idiopathic precocious puberty, gonadal dysgenesis, isolated gonadotropin deficiency, and constitutionally delayed growth and adolescence. J Clin Endocrinol Metab. 1980;51(3):548–56.

    Article  PubMed  CAS  Google Scholar 

  12. James VHT. The Endocrine function of the human adrenal cortex. Proceedings of the Serono Symposia; v. 18. London; New York: Academic; 1978. p. ix, 628.

    Google Scholar 

  13. Zhang LH, et al. Serine phosphorylation of human P450c 17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proc Natl Acad Sci USA. 1995;92(23):10,619–23.

    Article  CAS  Google Scholar 

  14. Miller WL, Auchus RJ, Geller DH. The regulation of 17,20 lyase activity. Steroids. 1997;62(1):133–42.

    Article  PubMed  CAS  Google Scholar 

  15. Braunstein GD. Gynecomastia. N Engl J Med. 1993; 328(7):490–5.

    Article  PubMed  CAS  Google Scholar 

  16. Herman-Giddens ME, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics. 1997;99(4):505–12.

    Article  PubMed  CAS  Google Scholar 

  17. Biro FM, McMahon RP, Striegel-Moore R, Crawford PB, Obarzanek E, Morrison JA, Barton BA, Falkner F. Impact of timing of pubertal maturation on growth in black and white female adolescents: the National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr. 2001;138:636–43.

    Article  PubMed  CAS  Google Scholar 

  18. Kaplowitz PR, Oberfield SE. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society. Pediatrics. 1999;104(4 Pt 1):936–41.

    Article  PubMed  CAS  Google Scholar 

  19. Rosenfield RL, et al. Current age of onset of puberty [letter]. Pediatrics. 2000;106(3):622–3.

    Article  PubMed  CAS  Google Scholar 

  20. Ibanez L, et al. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1993;76(6):1599–603.

    Article  PubMed  CAS  Google Scholar 

  21. Ibanez L, et al. Girls diagnosed with premature pubarche show an exaggerated ovarian androgen synthesis from the early stages of puberty: evidence from gonadotropin-releasing hormone agonist testing. Fertil Steril. 1997;67(5):849–55.

    Article  PubMed  CAS  Google Scholar 

  22. Ibanez L, de Zegher F, Potau N. Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset. J Endocrinol Invest. 1998;21(9):558–66.

    PubMed  CAS  Google Scholar 

  23. Ibanez L, et al. Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia. 1998;41(9):1057–63.

    Article  PubMed  CAS  Google Scholar 

  24. Ibanez L, Potau N, De Zegher F. Endocrinology and metabolism after premature pubarche in girls. Acta Paediatr Suppl. 1999;88(33):73–7.

    Article  PubMed  CAS  Google Scholar 

  25. Ibanez L, Potau N, de Zegher P. Recognition of a new association: reduced fetal growth, precocious pubarche, hyperinsulinism and ovarian dysfunction. Ann Endocrinol (Paris). 2000;61(2):141–2.

    CAS  Google Scholar 

  26. Volta C, et al. Isolated premature thelarche and thelarche variant clinical and auxological follow-up of 119 girls. J Endocrinol Invest. 1998;21(3):180–3.

    PubMed  CAS  Google Scholar 

  27. Ilicki A, et al. Premature thelarche—natural history and sex hormone secretion in 68 girls. Acta Paediatr Scand. 1984;73(6):756–62.

    Article  PubMed  CAS  Google Scholar 

  28. Pasquino AM, et al. Progression of premature thelarche to central precocious puberty. J Pediatr. 1995;126(1):11–4.

    Article  PubMed  CAS  Google Scholar 

  29. Mills JL, et al. Premature thelarche. Natural history and etiologic investigation. Am J Dis Child. 1981;135(8):743–5.

    PubMed  CAS  Google Scholar 

  30. Rosenfield RL. Normal and almost normal precocious variations in pubertal development premature pubarche and premature thelarche revisited. Horm Res. 1994;41 Suppl 2:7–13.

    Article  PubMed  Google Scholar 

  31. Jenner MR, et al. Hormonal changes in puberty. IV. Plasma estradiol, LH, and FSH in prepubertal children, pubertal females, and in precocious puberty, premature thelarche, hypogonadism, and in a child with a feminizing ovarian tumor. J Clin Endocrinol Metab. 1972;34(3):521–30.

    Article  PubMed  CAS  Google Scholar 

  32. Escobar ME, Rivarola MA, Bergada C. Plasma concentration of oestradiol-17beta in premature thelarche and in different types of sexual precocity. Acta Endocrinol (Copenh). 1976;81(2):351–61.

    CAS  Google Scholar 

  33. Colon I, et al. Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development [In Process Citation]. Environ Health Perspect. 2000;108(9):895–900.

    Article  PubMed  CAS  Google Scholar 

  34. Belgorosky A, Chaler E, Rivarola MA. High serum sex hormone-binding globulin (SHBG) in premature thelarche. Clin Endocrinol (Oxf). 1992;37(3): 203–6.

    Article  CAS  Google Scholar 

  35. Pescovitz OH, et al. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response 10 luteinizing hormone-releasing hormone. J Clin Endocrinol Metab. 1988;67(3):474–9.

    Article  PubMed  CAS  Google Scholar 

  36. Wang C, et al. Serum bioactive follicle-stimulating hormone levels in girls with precocious sexual development. J Clin Endocrinol Metab. 1990;70(3):615–9.

    Article  PubMed  CAS  Google Scholar 

  37. Verrotti A, et al. Premature thelarche: a long-term follow-up. Gynecol Endocrinol. 1996;10(4):241–7.

    Article  PubMed  CAS  Google Scholar 

  38. Aritaki S, et al. A comparison of patients with premature thelarche and idiopathic true precocious puberty in the initial stage of illness. Acta Paediatr Jpn. 1997;39(1):21–7.

    Article  PubMed  CAS  Google Scholar 

  39. Orley JN, Goblyos P. Modern imaging methods in paediatric breast examination. Ceska Gynekol. 1995;60(3):153–7.

    PubMed  CAS  Google Scholar 

  40. Salardi S, et al. Outcome of premature thelarche: relation to puberty and final height. Arch Dis Child. 1998;79(2):173–4.

    Article  PubMed  CAS  Google Scholar 

  41. Palmert MR, Malin HV, Boepple PA. Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated patients. J Clin Endocrinol Metab. 1999;84(2):415–23.

    Article  PubMed  CAS  Google Scholar 

  42. Ibanez L, et al. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab. 1998;83(10):3558–62.

    Article  PubMed  CAS  Google Scholar 

  43. Francois I, de Zegher F. Adrenarche and fetal growth. Pediatr Res. 1997;41:440–2.

    Article  PubMed  CAS  Google Scholar 

  44. Ibanez L, Potau N, de Zegher F. Precocious pubarche, dyslipidemia, and low IGF binding protein-1 in girls: relation to reduced prenatal growth. Pediatr Res. 1999;46(3):320–2.

    Article  PubMed  CAS  Google Scholar 

  45. Barker DJ, Hales CN, Fall CH, et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993;36:62–7.

    Article  PubMed  CAS  Google Scholar 

  46. Hawkins LA, Chasalow FL, Blethen SL. The role of adrenocorticotropin testing in evaluating girls with premature adrenarche and hirsutism/oligomenorrhea. J Clin Endocrinol Metab. 1992;74:248–53.

    Article  PubMed  CAS  Google Scholar 

  47. Speiser PW, Dupont B, Rubenstein P, Piazza A, Kastelan A, New MI. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet. 1985;37:650–67.

    PubMed  CAS  Google Scholar 

  48. Likitmaskul SC, Cowell CT, Donaghue K, et al. Exaggerated adrenarche in children presenting with premature adrenarche. Clin Endocrinol. 1995;42: 265–72.

    Article  CAS  Google Scholar 

  49. Temeck JW, et al. Genetic defects of steroidogenesis in premature pubarche. J Clin Endocrinol Metab. 1987;64(3):609–17.

    Article  PubMed  CAS  Google Scholar 

  50. Sizonenko PC, Paunier L. Hormonal changes in puberty III: correlation of plasma dehydroepiandrosterone, testosterone, FSI-I, and LH with stages of puberty and bone age in normal boys and girls and in patients with Addison’s disease or hypogonadism or with premature or late adrenarche. J Clin Endocrinol Metab. 1975;41(5):894–904.

    Article  PubMed  CAS  Google Scholar 

  51. Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med. 1996; 29:617–23.

    Article  Google Scholar 

  52. Moghetti P, Castello R, Negri C, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab. 2000;85:139–46.

    Article  PubMed  CAS  Google Scholar 

  53. Ibanez L, Valls C, Potua N, Marcos MV, de Zegher F. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, olgomenorrhia, dyslipidemia, and hyperinsulinism after precocious pubarche. J Clin Endocrinol Metab. 2000;85:3526–30.

    Article  PubMed  CAS  Google Scholar 

  54. Pescovitz OH, et al. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy. J Pediatr. 1986;108(1):47–54.

    Article  PubMed  CAS  Google Scholar 

  55. Robben SG, et al. Idiopathic isosexual central precocious puberty: magnetic resonance findings in 30 patients. Br J Radiol. 1995;68(805):34–8.

    Article  PubMed  CAS  Google Scholar 

  56. Mahachoklertwattana P, Kaplan SL, Grumbach MM. The luteinizing hormone-releasing hormone-secreting hypothalamic hamartoma is a congenital malformation: natural history. J Clin Endocrinol Metab. 1993;77(1):118–24.

    Article  PubMed  CAS  Google Scholar 

  57. Stewart L, Steinbok P, Daaboul J. Role of surgical resection in the treatment of hypothalamic hamartomas causing precocious puberty. Report of six cases. J Neurosurg. 1998;88(2):340–5.

    Article  PubMed  CAS  Google Scholar 

  58. Habiby R, et al. Precocious puberty in children with neurofibromatosis type 1. J Pediatr. 1995;126(3):364–7.

    Article  PubMed  CAS  Google Scholar 

  59. Oberfield SE, et al. Endocrine late effects of childhood cancers. J Pediatr. 1997;131(1 Pt 2):S37–41.

    PubMed  CAS  Google Scholar 

  60. Pescovitz OH, et al. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog. J Clin Endocrinol Metab. 1984;58(5):857–61.

    Article  PubMed  CAS  Google Scholar 

  61. Soliman AT, et al. Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog. Metabolism. 1997;46(5):513–7.

    Article  PubMed  CAS  Google Scholar 

  62. Foster CM, et al. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome. J Clin Endocrinol Metab. 1984;59(4):80l–5.

    Article  Google Scholar 

  63. Holland FJ, Kirsch SE, Selby S. Gonadotropin-independent precocious puberty (“testotoxicosis”); influence of maturational status on response to ketoconazole. J Clin Endocrinol Metab. 1987;64(2):328–33.

    Article  PubMed  CAS  Google Scholar 

  64. Eckert KL, et al. A single-sample, subcutaneous gonadotropin-releasing hormone test for central precocious puberty. Pediatrics. 1996;97(4):517–9.

    PubMed  CAS  Google Scholar 

  65. Rosenfield RL, et al. The rapid ovarian secretory response to pituitary stimulation by the ­gonadotropin-releasing hormone agonist nafarelin in sexual precocity. J Clin Endocrinol Metab. 1986; 63(6):1386–9.

    Article  PubMed  CAS  Google Scholar 

  66. Ibanez L, et al. Use of leuprolide acetate response ­patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin-releasing hormone test. J Clin Endocrinol Metab. 1994;78(1):30–5.

    Article  PubMed  CAS  Google Scholar 

  67. Rosenfield RL, et al. Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose-response studies and comparison to nafarelin—a clinical research center study. J Clin Endocrinol Metab. 1996;81(9):3408–11.

    Article  PubMed  CAS  Google Scholar 

  68. Boyar RM, et al. Twenty-four hour patterns of plasma luteinizing hormone and follicle-stimulating hormone in sexual precocity. N Engl J Med. 1973; 289(6):282–6.

    Article  PubMed  CAS  Google Scholar 

  69. Jakacki RK, Sauder RP, Lloyd SE, et al. Pulsatile secretion of luteinizing hormone in children. J Clin Endocrinol Metab. 1982;55:453–8.

    Article  PubMed  CAS  Google Scholar 

  70. Manasco PU, Muly DM, Godwin SM, et al. Ontogeny of gonadotrophin and inhibin secretion in normal girls through puberty based on overnight serial sampling, and comparison with normal boys. Hum Reprod. 1997;12:2108–14.

    Article  PubMed  CAS  Google Scholar 

  71. Mitamura R, Yano K, Suzuki N, Ito Y, Makita Y, Okuno A. Diurnal rhythms of luteinizing hormone, follicle-stimulating hormone, and testosterone secretion before the onset of male puberty. J Clin Endocrinol Metab. 1999;84:29–37.

    Article  PubMed  CAS  Google Scholar 

  72. Wu FB, Kelnar GE, Stirling CJH, Huhtaniemi HF. Patterns of pulsatile luteinizing and follicle-stimulating hormone secretion in prepubertal (midchildhood) boys and girls and patients with idiopathic hypogonadotrophic hypogonadism (Kallman’s syndrome): a study using an ultrasensitive time-resolved immunofluorometric assay. J Clin Endocrinol Metab. 1991;72:1229–37.

    Article  PubMed  CAS  Google Scholar 

  73. Hall DA, et al. Sonographic monitoring of LHRH analogue therapy in idiopathic precocious puberty in young girls. J Clin Ultrasound. 1986;14(5):331–8.

    Article  PubMed  CAS  Google Scholar 

  74. Cavallo A, et al. A simplified gonadotrophin-releasing hormone test for precocious puberty. Clin Endocrinol (Oxf). 1995;42(6):641–6.

    Article  CAS  Google Scholar 

  75. Oerter KE, et al. Effects of luteinizing hormone-releasing hormone agonists on final height in luteinizing hormone-releasing hormone-dependent precocious puberty. Acta Paediatr Suppl. 1993;388:62–8. discussion 69.

    PubMed  CAS  Google Scholar 

  76. Oostdijk W, et al. Final height in central precocious: puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child. 1996;75(4):292–7.

    Article  PubMed  CAS  Google Scholar 

  77. Oerter KE, et al. Adult height in precocious puberty after long-term treatment with deslorelin. J Clin Endocrinol Metab. 1991;73(6):1235–40.

    Article  PubMed  CAS  Google Scholar 

  78. Bar A, et al. Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height. J Pediatr. 1995;126(6):955–8.

    Article  PubMed  CAS  Google Scholar 

  79. Pasquino AM, et al. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty. J Clin Endocrinol Metab. 1996;81(3):948–51.

    Article  PubMed  CAS  Google Scholar 

  80. Saggese G, et al. Effect of combined treatment with gonadotropin releasing hormone analogue and growth hormone in patients with central precocious puberty who had subnormal growth velocity and impaired height prognosis. Acta Paediatr. 1995;84(3):299–304.

    Article  PubMed  CAS  Google Scholar 

  81. Walvoord EC, Pescovitz OH. Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty: theoretic and practical considerations. Pediatrics. 1999;104(4 Pt 2):1010–4.

    PubMed  CAS  Google Scholar 

  82. Neely EK, et al. Bone mineral density during treatment of central precocious puberty. J Pediatr. 1995; 127(5):819–22.

    Article  PubMed  CAS  Google Scholar 

  83. Bertelloni S, et al. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females. Eur J Pediatr. 1998;157(5):363–7.

    Article  PubMed  CAS  Google Scholar 

  84. Lazar L, et al. Early polycystic ovary-like syndrome in girls with central precocious puberty and exaggerated adrenal response. Eur J Endocrinol. 1995; 133(4):403–6.

    Article  PubMed  CAS  Google Scholar 

  85. Jay N, et al. Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab. 1992;75(3):890–4.

    Article  PubMed  CAS  Google Scholar 

  86. Saenz CA, et al. Premature thelarche and ovarian cyst probably secondary to estrogen contamination. Bol Asoc Med P R. 1982;74(2):16–9.

    PubMed  CAS  Google Scholar 

  87. Saenz de Rodriguez CA, Toro-Sola MA. Anabolic steroids in meat and rema premature telarche. Lancet. 1982;1(8284):1300.

    Article  PubMed  CAS  Google Scholar 

  88. Saenz de Rodriguez CA, Bongiovanni AM, Conde de Borrego L. An epidemic of precocious development in Puerto Rican children. J Pediatr. 1985;107(3):393–6.

    Article  PubMed  CAS  Google Scholar 

  89. Cohen HE, Eisenberg P, Mandel F, Haller JO. Ovarian cysts are common in premenarchal girls: a sonographic study of 101 children 2–12 yr old. AJR Am J Roentgenol. 1992;159(1):89.

    PubMed  CAS  Google Scholar 

  90. Albright FB, Hampton AM. Syndrome characterized by osteitis fibrosa disseminata, areas of depigmentation and endocrine dysfunction, with precocious puberty in females. N Engl J Med. 1937;216:727.

    Article  Google Scholar 

  91. Weinstein LS, et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 1991;325(24):1688–95.

    Article  PubMed  CAS  Google Scholar 

  92. Shenker A, et al. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab. 1994; 79(3):750–5.

    Article  PubMed  CAS  Google Scholar 

  93. Shenker A, et al. Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr. 1993;123(4):509–18.

    Article  PubMed  CAS  Google Scholar 

  94. Pienkowski C, et al. Recurrent ovarian cyst and mutation of the Gs alpha gene in ovarian cyst fluid cells: what is the link with McCune-Albright syndrome? Acta Paediatr. 1997;86(9):1019–21.

    Article  PubMed  CAS  Google Scholar 

  95. DiMeglio LA, Pescovitz OH. Disorders of puberty: inactivating and activating molecular mutations. J Pediatr. 1997;131(1 Pt 2):S8–12.

    PubMed  CAS  Google Scholar 

  96. Mastorakos G, et al. Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty yr after the first report. Thyroid. 1997; 7(3):433–9.

    Article  PubMed  CAS  Google Scholar 

  97. Cavanah SF, Dons RF. McCune-Albright syndrome: how many endocrinopathies can one patient have? South Med J. 1993;86(3):34–7.

    Article  Google Scholar 

  98. Lee PA, Van Dop C, Migeon CJ. McCune-Albright syndrome. Long-term follow-up. JAMA. 1986; 256(21):2980–4.

    Article  PubMed  CAS  Google Scholar 

  99. Holland FJ. Gonadotropin-independent precocious puberty. Endocrinol Metab Clin North Am. 1991; 20(1):191–210.

    PubMed  CAS  Google Scholar 

  100. Benedict PH. Sex precocity and polyostotic fibrous dysplasia. Report of a case in a boy with testicular biopsy. Am J Dis Child. 1966;111(4):426–9.

    PubMed  CAS  Google Scholar 

  101. Foster CM, et al. Ovarian function in girls with McCune-Albright syndrome. Pediatr Res. 1986; 20(9):859–63.

    Article  PubMed  CAS  Google Scholar 

  102. Schmidt H, Kiess W. Secondary central precocious puberty in a girl with McCune-Albright syndrome responds to treatment with GnRH analogue. J Pediatr Endocrinol Metab. 1998;11(1):77–81.

    Article  PubMed  CAS  Google Scholar 

  103. Sorgo W, et al. The effects of cyproterone acetate on statural growth in children with precocious puberty. Acta Endocrinol (Copenh). 1987;115(1): 44–56.

    CAS  Google Scholar 

  104. Feuillan PP, et al. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone. N Engl J Med. 1986; 315(18):1115–9.

    Article  PubMed  CAS  Google Scholar 

  105. Feuillan PP, Jones J, Cutler Jr GB. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright, syndrome. J Clin Endocrinol Metab. 1993;77(3):647–51.

    Article  PubMed  CAS  Google Scholar 

  106. Eugster EA, et al. Tamoxifen treatment of progressive precocious puberty in a patient with McCune-Albright, syndrome. J Pediatr Endocrinol Metab. 1999;12(5):681–6.

    Article  PubMed  CAS  Google Scholar 

  107. Shenker A, et al. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty [see comments]. Nature. 1993;365(6447):652–4.

    Article  PubMed  CAS  Google Scholar 

  108. Kremer H, et al. Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum Mol Genet. 1993;2(11):1779–83.

    Article  PubMed  CAS  Google Scholar 

  109. Kraaij R, et al. A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familial male-limited precocious puberty. J Clin Endocrinol Metab. 1995;80(11):3168–72.

    Article  PubMed  CAS  Google Scholar 

  110. Gromoll J, et al. A mutation in the first transmembrane domain of the lutropin receptor causes male precocious puberty. J Clin Endocrinol Metab. 1998;83(2):476–80.

    Article  PubMed  CAS  Google Scholar 

  111. Laue L, et al. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. Proc Natl Acad Sci USA. 1995;92(6):1906–10.

    Article  PubMed  CAS  Google Scholar 

  112. Latronico AC, et al. A unique constitutively activating mutation in third transmembrane helix of luteinizing hormone receptor causes sporadic male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab. 1998;83(7):2435–40.

    Article  PubMed  CAS  Google Scholar 

  113. Schedewie HK, et al. Testicular leydig cell hyperplasia as a cause of familial sexual precocity. J Clin Endocrinol Metab. 1981;52(2):271–8.

    Article  PubMed  CAS  Google Scholar 

  114. Clark PA, Clarke WL. Testotoxicosis. An unusual presentation and novel gene mutation. Clin Pediatr (Phila). 1995;34(5):271–4.

    Article  CAS  Google Scholar 

  115. Reiter EO, et al. Male-limited familial precocious puberty in three generations. Apparent Leydig-cell autonomy and elevated glycoprotein hormone alpha subunit. N Engl J Med. 1984;311(8):515–9.

    Article  PubMed  CAS  Google Scholar 

  116. Egli CA, et al. Pituitary gonadotropin-independent male-limited autosomal dominant sexual precocity in nine generations: familial testotoxicosis. J Pediatr. 1985;106(1):33–40.

    Article  PubMed  CAS  Google Scholar 

  117. Kawate N. Identification of constitutively activating mutation of the luteinising hormone receptor in a family with male limited gonadotrophin independent precocious puberty (testotoxicosis). J Med Genet. 1995;32(7):553–4.

    Article  PubMed  CAS  Google Scholar 

  118. Rosenthal SM, Grumbach MM, Kaplan SL. Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases. J Clin Endocrinol Metab. 1983;57(3): 571–9. 119.

    Article  PubMed  CAS  Google Scholar 

  119. Holland FJ, et al. Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy. N Engl J Med. 1985;312(16):1023–8.

    Article  PubMed  CAS  Google Scholar 

  120. Laue L, et al. Treatment of familial male precocious puberty with spironolactone and testolactone. N Engl J Med. 1989;320(8):496–502.

    Article  PubMed  CAS  Google Scholar 

  121. Babovic-Vuksanovic D, et al. Hazards of ketoconazole therapy in testotoxicosis. Acta Paediatr. 1994; 83(9):994–7.

    Article  PubMed  CAS  Google Scholar 

  122. Laue L, et al. Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin. J Clin Endocrinol Metab. 1993;76(1):151–5.

    Article  PubMed  CAS  Google Scholar 

  123. Skinner MA, et al. Ovarian neoplasms in children. Arch Surg. 1993;128(8):849–53. discussion 853–4.

    Article  PubMed  CAS  Google Scholar 

  124. Bouffet E, et al. Juvenile granulosa cell tumor of the ovary in infants: a clinicopathologic study of three cases and review of the literature. J Pediatr Surg. 1997;32(5):762–5.

    Article  PubMed  CAS  Google Scholar 

  125. Nakashima N, Young RH, Scully RE. Androgenic granulosa cell tumors of the ovary. A clinicopathologic analysis of 17 cases and review of the literature. Arch Pathol Lab Med. 1984;108(10):786–91.

    PubMed  CAS  Google Scholar 

  126. Cronje HS, et al. Granulosa and theca cell tumors in children: a report of 17 cases and literature review. Obstet Gynecol Surv. 1998;53(4):240–7.

    Article  PubMed  CAS  Google Scholar 

  127. Bas F, Pescovitz OH, Steinmetz R. No activating mutations of FSH receptor in four children with ovarian juvenile granulosa cell tumors and the association of these tumors with central precocious puberty. J Pediatr Adolesc Gynecol, 2009;22(3):173–9.

    Google Scholar 

  128. Masur Y, et al. Leydig cell tumors of the testis—clinical and morphologic aspects. Urologe A. 1996; 35(6):468–71.

    Article  PubMed  CAS  Google Scholar 

  129. Diamond Jr FB, et al. Hetero- and isosexual pseudoprecocity associated with testicular sex-cord tumors in an 8 year-old male. J Pediatr Endocrinol Metab. 1996;9(3):407–14.

    Article  PubMed  Google Scholar 

  130. Kim I, Young RH, Scully RE. Leydig cell tumors of the testis. A clinicopathological analysis of 40 cases and review of the literature. Am J Surg Pathol. 1985;9(3):177–92.

    Article  PubMed  CAS  Google Scholar 

  131. Comite F, et al. Isosexual precocious pseudopuberty secondary to a feminizing adrenal tumor. J Clin Endocrinol Metab. 1984;58(3):435–40.

    Article  PubMed  CAS  Google Scholar 

  132. Heimann A, et al. Hepatoblastoma presenting as isosexual precocity. The clinical importance of histologic and serologic parameters. J Clin Gastroenterol. 1987;9(1):105–10.

    Article  PubMed  CAS  Google Scholar 

  133. Otsuka T, et al. Primary pulmonary choriocarcinoma in a four month old boy complicated with precocious puberty. Acta Paediatr Jpn. 1994;36(4):404–7.

    Article  PubMed  CAS  Google Scholar 

  134. Derenoncount AN, Castro-Magana M, Jones KL. Mediastinal teratoma and precocious puberty in a boy with mosaic Klinefelter syndrome. Am J Med Genet. 1995;55(1):38–42. 135.

    Article  Google Scholar 

  135. Cohen AR, Wilson JA, Sadeghi-Nejad A. Gonadotropin-secreting pineal teratoma causing precocious puberty. Neurosurgery. 1991;28(4):597–602. discussion 602–3, 136.

    Article  PubMed  CAS  Google Scholar 

  136. Tamaki N, et al. Germ cell tumors of the thalamus and the basal ganglia. Childs Nerv Syst. 1990;6(1):3–7. 137.

    Article  PubMed  CAS  Google Scholar 

  137. Kukuvitis A, Matte C, Polychronakos C. Central precocious puberty following feminizing right ovarian granulosa cell tumor. Horm Res. 1995;44(6):268–70.

    Article  PubMed  CAS  Google Scholar 

  138. Leschek EW, et al. Localization by venous sampling of occult chorionic gonadotropin-secreting tumor in a boy with mosaic Klinefelter’s syndrome and precocious puberty. J Clin Endocrinol Metab. 1996; 81(11):3825–8.

    Article  PubMed  CAS  Google Scholar 

  139. Englund AT, et al. Pediatric germ cell and human chorionic gonadotropin-producing tumors. Clinical and laboratory features. Am J Dis Child. 1991; 145(11):1294–7.

    PubMed  CAS  Google Scholar 

  140. Hasle H, et al. Mediastinal germ cell tumour associated with Klinefelter syndrome. A report of case and review of the literature. Eur J Pediatr. 1992; 151(10):735–9.

    Article  PubMed  CAS  Google Scholar 

  141. Van Wyk JG. Syndrome of precocious menstruation and galactorrhea in juvenile hypothyroidism: an example of hormonal overlap in pituitary feedback. J Pediatr. 1960;57:416.

    Article  Google Scholar 

  142. Lindsay AV, MacGillivray ML. Multicystic ovaries detected by sonography. Am J Dis Child. 1980; 134:588–92.

    PubMed  CAS  Google Scholar 

  143. Bruder JS, Bremner MH, Ridgway WJ, Wierman EC. Hypothyroidism-induced macroorchidism: use of a gonadotropin-releasing agonist to understand its mechanism and augment adult stature. J Clin Endocrinol Metab. 1995;80:11–6.

    Article  PubMed  CAS  Google Scholar 

  144. Anasti JN, et al. A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab. 1995;80(1):276–9.

    Article  PubMed  CAS  Google Scholar 

  145. Desforges J. Gynecomastia. N Engl J Med. 1993; 328(7):490.

    Article  Google Scholar 

  146. Coen P. An aromatase-producing sex-cord tumor resulting in prepubertal gynecomastia. N Engl J Med. 1991;324(5):317.

    Article  PubMed  CAS  Google Scholar 

  147. Halperin DS, Sizonenko PC. Prepubertal gynecomastia following topical inunction of estrogen containing ointment. Helv Paediatr Acta. 1983;38(4):361–6.

    PubMed  CAS  Google Scholar 

  148. Edidin DL. Prepubertal gynecomastia associated with estrogen-containing hair cream. Am J Dis Child. 1982;136(7):587.

    PubMed  CAS  Google Scholar 

  149. Latorre HK. Idiopathic gynecomastia in seven preadolescent boys. Am J Dis Child. 1973;126:771.

    PubMed  CAS  Google Scholar 

  150. Stratakis CA, et al. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. J Clin Endocrinol Metab. 1998;83(4):1348–57.

    Article  PubMed  CAS  Google Scholar 

  151. Fontoura M, et al. Precocious puberty in girls: early diagnosis of a slowly progressing variant. Arch Dis Child. 1989;64(8):1170–6.

    Article  PubMed  CAS  Google Scholar 

  152. Kreiter M, et al. Preserving adult height potential in girls with idiopathic true precocious puberty. J Pediatr. 1990;117(3):364–70.

    Article  PubMed  CAS  Google Scholar 

  153. Bassi F, et al. Precocious puberty: auxological criteria discriminating different forms. J Endocrinol Invest. 1994;17(10):793–7.

    PubMed  CAS  Google Scholar 

  154. Leger J, Reynaud R, Czernichow P. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment? J Pediatr. 2000;137(6):819–25.

    Article  PubMed  CAS  Google Scholar 

  155. Brauner R, et al. Adult height in girls with idiopathic true precocious puberty. J Clin Endocrinol Metab. 1994;9(2):415–20.

    Article  Google Scholar 

  156. Ghirri P, et al. Final height in girls with slowly progressive untreated central precocious puberty. Gynecol Endocrinol. 1997;11(5):301–5.

    Article  PubMed  CAS  Google Scholar 

  157. Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerroni F. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone, analogues and growth hormone. J Clin Endocrinol Metab. 1999;84:449–52.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. USF Diabetes Center, University of South Florida-USF Health, Tampa, FL, USA

    Henry Rodriguez M.D.

  2. University of South Florida/All Children’s Hospital, St. Petersburg, FL, USA

    Grace C. Dougan M.D.

Authors
  1. Henry Rodriguez M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Grace C. Dougan M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Henry Rodriguez M.D. .

Editor information

Editors and Affiliations

  1. School of Medicine, Department of Pediatrics, The Johns Hopkins University, 600 North Wolfe St., Baltimore, 21287, Maryland, USA

    Sally Radovick

  2. , Department of Pediatrics, Children's Hospital of Buffalo, 219 Bryant St., Buffalo, 14222, New York, USA

    Margaret H. MacGillivray

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Rodriguez, H., Dougan, G.C. (2013). Precocious Puberty: Clinical Management. In: Radovick, S., MacGillivray, M. (eds) Pediatric Endocrinology. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-395-4_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-395-4_23

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-394-7

  • Online ISBN: 978-1-60761-395-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation